The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

Cholesterol-lowering drugs (statins) reduce heart disease risk and death in adults with type 2 diabetes, making them a key ...

Older adults without cardiovascular disease derive as much benefit from statin therapy as younger patients, with the reduction in CVD risk not coming at the expense of increased adverse events, an ...

So, you’ve heard about statins. Maybe your doctor mentioned them, or perhaps you saw a commercial with happy, healthy-looking people strolling through a park. The big question on your mind is probably ...

Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...